Cargando…
P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430046/ http://dx.doi.org/10.1097/01.HS9.0000973588.27391.ea |
| _version_ | 1785090859980554240 |
|---|---|
| author | Tedeschi, Alessandra Tam, Constantine Owen, Roger Buske, Christian Leblond, Véronique Dimopoulos, Meletios A. García-Sanz, Ramón Castillo, Jorge Trotman, Judith Treon, Steven Yang, Keri Tang, Boxiong Allewelt, Heather Patel, Sheel Chan, Wai Cohen, Aileen Schneider, Jingjing Yan Barnes, Gisoo |
| author_facet | Tedeschi, Alessandra Tam, Constantine Owen, Roger Buske, Christian Leblond, Véronique Dimopoulos, Meletios A. García-Sanz, Ramón Castillo, Jorge Trotman, Judith Treon, Steven Yang, Keri Tang, Boxiong Allewelt, Heather Patel, Sheel Chan, Wai Cohen, Aileen Schneider, Jingjing Yan Barnes, Gisoo |
| author_sort | Tedeschi, Alessandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430046 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104300462023-08-17 P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP Tedeschi, Alessandra Tam, Constantine Owen, Roger Buske, Christian Leblond, Véronique Dimopoulos, Meletios A. García-Sanz, Ramón Castillo, Jorge Trotman, Judith Treon, Steven Yang, Keri Tang, Boxiong Allewelt, Heather Patel, Sheel Chan, Wai Cohen, Aileen Schneider, Jingjing Yan Barnes, Gisoo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430046/ http://dx.doi.org/10.1097/01.HS9.0000973588.27391.ea Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Tedeschi, Alessandra Tam, Constantine Owen, Roger Buske, Christian Leblond, Véronique Dimopoulos, Meletios A. García-Sanz, Ramón Castillo, Jorge Trotman, Judith Treon, Steven Yang, Keri Tang, Boxiong Allewelt, Heather Patel, Sheel Chan, Wai Cohen, Aileen Schneider, Jingjing Yan Barnes, Gisoo P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP |
| title | P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP |
| title_full | P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP |
| title_fullStr | P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP |
| title_full_unstemmed | P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP |
| title_short | P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP |
| title_sort | p1679: health-related quality of life in patients (pts) with waldenström macroglobulinemia (wm) treated with zanubrutinib (zanu) vs ibrutinib (ibr): results from the phase 3 aspen trial long-term follow-up |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430046/ http://dx.doi.org/10.1097/01.HS9.0000973588.27391.ea |
| work_keys_str_mv | AT tedeschialessandra p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT tamconstantine p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT owenroger p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT buskechristian p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT leblondveronique p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT dimopoulosmeletiosa p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT garciasanzramon p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT castillojorge p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT trotmanjudith p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT treonsteven p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT yangkeri p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT tangboxiong p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT alleweltheather p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT patelsheel p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT chanwai p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT cohenaileen p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT schneiderjingjingyan p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup AT barnesgisoo p1679healthrelatedqualityoflifeinpatientsptswithwaldenstrommacroglobulinemiawmtreatedwithzanubrutinibzanuvsibrutinibibrresultsfromthephase3aspentriallongtermfollowup |